Citius PharmaceuticalsCTXR
13F holders, Q1 2026 (March 31)38holders −1
6new positions
9sold out
$0.90avg. 13F price*
At the end of Q1 2026, 38 institutions reported holding Citius Pharmaceuticals Inc. (CTXR) in their 13F filings, down 1 from Q4 2025. 6 opened new positions and 9 sold out. The largest holders were Geode Capital Management, LLC ($222K), Vanguard Capital Management LLC ($151K) and Vanguard Fiduciary Trust Co. ($70K).
- Company
- Citius Pharmaceuticals Inc.
- CUSIP
- 17322U306
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $68K |
| Exits | 9 | $661K |
All 13F filers, Q4 2025 → Q1 2026: 234,320 shares bought and 1,005,983 shares sold, net −771,663 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 38 holders
| Geode Capital Management, LLC | 0.00% | Add +93.0% | 246,158 | $222K |
| Vanguard Capital Management LLC | 0.00% | — | 167,738 | $151K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 77,755 | $70K |
| BlackRock, Inc. | 0.00% | No change | 69,851 | $63K |
| HRT Financial LP | 0.00% | New | 60,332 | $54K |
| Asset Advisory Group, Inc. | 0.03% | No change | 59,011 | $53K |
| UBS Group AG | 0.00% | Reduce -28.0% | 55,025 | $50K |
| Northern Trust Corp. | 0.00% | No change | 43,974 | $40K |
| Susquehanna International Group, LLP | 0.00% | Add +185.6% | 36,838 | $33K |
| LPL Financial LLC | 0.00% | Reduce -0.1% | 25,045 | $23K |
| State Street Corp. | 0.00% | No change | 23,271 | $21K |
| Jane Street Group, LLC | 0.00% | Add +25.4% | 22,523 | $20K |
| XTX Topco Ltd | 0.00% | Reduce -80.1% | 21,295 | $19K |
| Arkadios Wealth Advisors | 0.00% | No change | 20,000 | $18K |
| Miller Financial Services LLC | 0.01% | New | 14,000 | $13K |
| Two Sigma Investments, LP | 0.00% | Reduce -78.4% | 13,138 | $12K |
| IFP Advisors, Inc | 0.00% | No change | 7,083 | $6K |
| SBI Securities Co., Ltd. | 0.00% | Add +62.2% | 6,519 | $6K |
| Citigroup Inc. | 0.00% | Add +520.2% | 5,228 | $5K |
| Chelsea Counsel Co. | 0.00% | No change | 4,626 | $4K |
| Quent Capital, LLC | 0.00% | Add +361.1% | 4,265 | $4K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -0.8% | 2,785 | $3K |
| Osaic Holdings, Inc. | 0.00% | Add +83.9% | 2,735 | $2K |
| Curio Wealth, LLC | 0.00% | No change | 2,000 | $2K |
| Vanguard Global Advisers, LLC | 0.00% | — | 1,788 | $2K |
| Morgan Stanley | 0.00% | Reduce -32.9% | 1,364 | $1K |
| Ameritas Advisory Services, LLC | 0.00% | New | 1,000 | $900 |
| NewEdge Advisors, LLC | 0.00% | No change | 400 | $360 |
| Assetmark, Inc. | 0.00% | New | 372 | $335 |
| Murphy & Mullick Capital Management Corp | 0.00% | No change | 160 | $144 |
| Princeton Global Asset Management LLC | 0.00% | No change | 160 | $144 |
| Smallwood Wealth Investment Management, LLC | 0.00% | No change | 120 | $108 |
| BNP Paribas Financial Markets | 0.00% | No change | 107 | $96 |
| JPMorgan Chase & Co. | 0.00% | No change | 120 | $82 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 80 | $72 |
| Fairscale Capital, LLC | 0.00% | No change | 42 | $38 |
| Northwestern Mutual Wealth Management Co. | 0.00% | New | 8 | $8 |
| Bogart Wealth, LLC | 0.00% | New | 4 | $4 |
"% of holder's portfolio" is CTXR's weight in each manager's 13F, not the share of Citius Pharmaceuticals Inc. the manager owns.